Weight Care and Your Eyes: The One Sign to Know After the FDA's November 2026 Label Update On November 9, 2026 the FDA added a potential, rare eye condition (NAION) to the labels of a whole class of weight-care and diabetes medicines. In 126 trials it occurred 6.4 times per 100,000 person-years vs 3.8 on comparison treatments, from only 15 probable cases. The sign to know: sudden, painless vision change in one eye. Contact your provider right away if it happens. Education only; a licensed provider decides every treatment. Can weight loss injections affect your eyes? The FDA now lists a potential, rare eye condition on these medicine labels, so the key is knowing one sign: sudden, painless vision change in one eye. HOO Longevity in the United States connects you with a licensed provider who reviews your eye health and full history as part of weight care. Sources: FDA Drug Safety Communication, 2026: https://www.fda.gov/drugs/drug-safety-communications/fda-requires-safety-labeling-changes-glucagon-peptide-1-receptor-agonists-glp-1-ras-due-potential Learn this with HOO Longevity Academy by Join HOO Health: research-backed lessons and a new reel, carousel and story every day, in your own brand. Free Academy Live class every Tuesday evening. joinhoohealth.com/academy Education only, not medical advice. Rx programs require an online visit with a licensed provider. Results vary. #weightcare #metabolichealth #healthyhabits #Shorts #HOOLongevityAcademy #JoinHOOHealth